Akèy › Maladi Crohn › Virginia › Richmond
Etid klinik pou Maladi Crohn nan Richmond, VA
6 etid pou Maladi Crohn ap chèche patisipan nan sit nan ak bò kote Richmond (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
Ap rekriteFaz 3
- Richmond VA Medical Center ( Site 5021), Richmond
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
Ap rekriteFaz 2
- GI Alliance - Richmond /ID# 284244, Richmond
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Ap rekriteFaz 1
- VCU Massey Comprehensive Cancer Center, Richmond
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 3
- Clinical Research Partners-Site Number: 8400080, Richmond
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Ap rekriteFaz 2
- Richmond VA Medical Center, Richmond
A Study to Investigate Efficacy and Safety of SAR442970 in Patients With Crohn's Disease
Ap rekriteFaz 2
- Investigational Site Number: 8400027, Richmond
Etid Maladi Crohn nan lòt vil
- New York City, NY35 etid
- Cleveland, OH19 etid
- St. Louis, MO19 etid
- Boston, MA19 etid
- Miami, FL19 etid
- Orlando, FL17 etid
- Houston, TX17 etid
- Atlanta, GA17 etid
- Tyler, TX16 etid
- San Diego, CA15 etid
- San Antonio, TX15 etid
- Los Angeles, CA15 etid
Lòt etid nan Richmond
- Kansè nan tete26 etid
- Kansè Poumon ki pa ti selil25 etid
- Kansè pwostat19 etid
- Ensifizyans kadyak16 etid
- Kansè poumon14 etid
- Kansè kolorektal13 etid
- Maladi kadyovaskilè13 etid
- Maladi fwa steatotik12 etid
- Leksemi mieloïd egi12 etid
- Karsinòm selil skuamèz tèt ak kou12 etid
- Kansè Metastatik12 etid
- Melanom11 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.